Publications by authors named "Anis Hamid"

Claim this Profile
I
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer.
Aaron P Mitchell, Andrew Salner, Paul Palyca, Azeez Farooki, Sonia Persaud, Dedipya Bhamidipati, Anis Hamid

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.
Emily Grist, Peter Dutey-Magni, Marina A Parry, Larissa Mendes, Ashwin Sachdeva, Anis A Hamid

Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of evolutionary divergence in prostate cancer.
Emre Esentürk, Atef Sahli, Valeriia Haberland, Aleksandra Ziuboniewicz, Christopher Wirth, Anis Hamid

ArXiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision medicine for prostate cancer: An international perspective.
Anis A Hamid, Christopher J Sweeney, Christopher Hovens, Niall Corcoran, Arun A Azad

Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.
Katherine L Morel, Beatriz Germán, Anis A Hamid, Jagpreet S Nanda, Simon Linder

J Clin Invest· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer.
Santosh Gupta, Luisa Fernandez, David Bourdon, Anis A Hamid, Anupama Pasam

J Circ Biomark· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Adam B Weiner, Yang Liu, Alex Hakansson, Xin Zhao, James A Proudfoot, Anis A Hamid

Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment.
Anis A Hamid, Nicolas Sayegh, Bertrand Tombal, Maha Hussain, Christopher J Sweeney

Am Soc Clin Oncol Educ Book· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.
Gary Edward Richardson, Raed Al-Rajabi, Dipesh Uprety, Anis Hamid, Stephen K Williamson

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial.
Marina A Parry, Emily Grist, Larissa Mendes, Peter Dutey-Magni, Ashwin Sachdeva, Anis A Hamid

Res Sq· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
Alexius John, Lavinia Spain, Anis A Hamid

Curr Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of copy number alterations and clinical progression across advanced prostate cancer.
Emily Grist, Stefanie Friedrich, Christopher Brawley, Larissa Mendes, Marina Parry, Anis A Hamid

Genome Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.
Philip Sutera, Kim Van Der Eecken, Amar U Kishan, Anis Hamid, Emily Grist

Prostate Cancer Prostatic Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.
Nieves Martinez Chanza, Brandon Bernard, Philippe Barthelemy, Anna Accarain, Marianne Paesmans, Anis A Hamid

Prostate Cancer Prostatic Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry.
Xiao X Wei, Lucia Kwak, Anis Hamid, Monica He, Christopher Sweeney

Prostate Cancer Prostatic Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testicular seminoma metastases presenting as gastrointestinal malignancy: A case report and review of the literature.
Alice Thomson, Ben Keong, Anthony Longano, Anis Hamid, Shomik Sengupta

ANZ J Surg· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Koen Degeling, Niall M Corcoran, Amanda Pereira-Salgado, Anis A Hamid, Shankar Siva

Value Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Christian Daniel Fankhauser, Ben Tran, Manuel Pedregal, José Manuel Ruiz-Morales, Egon Gonzalez-Billalabeitia, Anis A Hamid

Eur Urol Focus· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants.
Katherine L Morel, Anis A Hamid, John G Clohessy, Nicole Pandell, Leigh Ellis

Mol Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Victoria Wang, Milan S Geybels, Kristina M Jordahl, Travis Gerke, Anis Hamid

Prostate· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.
Katherine L Morel, Anjali V Sheahan, Deborah L Burkhart, Sylvan C Baca, Nadia Boufaied, Anis A Hamid

Nat Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between CD8 and PD-L1 expression and outcomes after radical prostatectomy for localized prostate cancer.
Cecile Vicier, Praful Ravi, Lucia Kwak, Lillian Werner, Ying Huang, Anis A Hamid

Prostate· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline serum IL-8 on metastatic hormone-sensitive prostate cancer outcomes in the Phase 3 CHAARTED trial (E3805).
Lauren C Harshman, Victoria X Wang, Anis A Hamid, Gabriella Santone, Charles G Drake

Prostate· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.
Alba Font-Tello, Nikolas Kesten, Yingtian Xie, Len Taing, Damir Varešlija, Anis A Hamid

Nat Protoc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nursing Implications of Recent Changes in Management Practices for Metastatic Prostate Cancer.
Caitlin Bennett, Ian D Davis, Anis A Hamid

Semin Oncol Nurs· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis